Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001171843-17-004905)

Filing Details

Accession Number:
0001171843-17-004905
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-09 18:01:19
Reporting Period:
2017-08-04
Filing Date:
2017-08-09
Accepted Time:
2017-08-09 18:01:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
3116 Akorn Inc AKRX Pharmaceutical Preparations (2834) 720717400
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1467848 Brian Tambi 1925 West Field Court Suite 300
Lake Forest IL 60045		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-08-04 5,165 $33.37 66,175 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the weighted average sale price of the shares sold. The shares were sold at prices ranging from $33.35 to $33.44. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at separate prices within the foregoing range.
  2. Following the reported transaction, the amount of shares beneficially owned includes 14,434 unvested RSUs and 51,741 shares owned outright.